Ten Illinois bioengineering researchers have been selected to become part of the inaugural cohort of Chan Zuckerberg Biohub Chicago Investigators. The 48-member group, which will focus on instrumented tissues, inflammation, and the functions of the immune system, also includes investigators from Northwestern University and University of Chicago.
The biohub, which was announced in 2023, brings together researchers to develop technologies capable of making precise, molecular-level measurements of biological processes within human tissues. Understanding and treating the inflammatory states that underlie many diseases is its ultimate goal.
“The CZ Biohub Chicago is focused on high-risk, high-reward research, and the selection of these 16 Illinois investigators—from so many colleges and institutes across the university—underscores the breadth of research excellence on our campus," said Susan Martinis, the vice chancellor for research and innovation at Illinois.
U. of I colleges and research institutes represented in the Biohub cohort include the Carle Illinois College of Medicine, Grainger College of Engineering, the College of Liberal Arts & Sciences, the College of Veterinary Medicine, the Beckman Institute for Advanced Science and Technology, the Cancer Center at Illinois, the Carl R. Woese Institute for Genomic Biology, and NCSA.
The following department of bioengineering researchers are part of the inaugural cohort:
Click here for the original article and full list of Illinois researchers.